GlassScriptPhysician profile
Wendy G Fields
NPI 1700978848
$2,690.67
in general payments reported to CMS, 2019-2025
18 companies · $598 in 2025
The $598 reported for 2025 was more than what 76% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $134 · 2022: $46.12 · 2023: $1,138 · 2024: $775 · 2025: $598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,510.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $964.34 | 2021-2025 | Watchman Access System, Watchman Flx, Avvigo Guidance System |
| Shockwave Medical, INC | $352.53 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $279.32 | 2023-2025 | Xience Skypoint, Aveir, Cardiomems |
| Abiomed | $265.85 | 2024-2025 | Impella |
| Atricure, INC. | $161.19 | 2023-2024 | |
| Medtronic, INC. | $102.57 | 2023-2024 | Azure Xt Dr Mri Surescan, Micra |
| E.R. Squibb & Sons, L.L.C. | $96.70 | 2021-2023 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $93.86 | 2021-2023 | Farxiga |
| Novartis Pharmaceuticals Corporation | $81.33 | 2021-2023 | |
| Convatec INC. | $61.15 | 2022-2024 | |
| Amgen INC. | $52.92 | 2023 | Repatha |
| Cardiva Medical, INC. | $38.83 | 2024-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade 6/7f Vcs |
| Lantheus Medical Imaging, INC. | $27.68 | 2023 | Definity |
| Janssen Pharmaceuticals, INC | $27.39 | 2022-2023 | Xarelto |
| Daiichi Sankyo INC. | $27.14 | 2023 | Injectafer |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $25.17 | 2024 | Turnpike |
| Pfizer INC. | $16.45 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendy Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.